应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03320 华润医药
交易中 11-10 14:21:46
4.635
-0.030
-0.64%
最高
4.675
最低
4.620
成交量
241.10万
今开
4.665
昨收
4.665
日振幅
1.18%
总市值
291.22亿
流通市值
291.19亿
总股本
62.83亿
成交额
1,118万
换手率
0.04%
流通股本
62.83亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
华润医药10月股份变动月报表,股本维持不变
公告速递 · 11-02
华润医药10月股份变动月报表,股本维持不变
华润医药(03320.HK):华润医药商业前三季度归母净利润14.2亿元 同比增长5.62%
智通财经 · 10-30
华润医药(03320.HK):华润医药商业前三季度归母净利润14.2亿元 同比增长5.62%
华润医药2026年前三季度营收1694.60亿元,净利润17.46亿元
公告速递 · 10-30
华润医药2026年前三季度营收1694.60亿元,净利润17.46亿元
华润医药2026年前三季度营收8.47亿元,净利润6,058.83万元
公告速递 · 10-29
华润医药2026年前三季度营收8.47亿元,净利润6,058.83万元
华润医药(03320.HK):华润博雅生物前三季度净利润6058.83万元 同比减少82.34%
智通财经 · 10-29
华润医药(03320.HK):华润博雅生物前三季度净利润6058.83万元 同比减少82.34%
华润医药2026年前三季度营收2035.28亿元
公告速递 · 10-28
华润医药2026年前三季度营收2035.28亿元
华润医药(03320):华润医药控股前三季度归母净利润23.91亿元 同比减少6.73%
智通财经 · 10-28
华润医药(03320):华润医药控股前三季度归母净利润23.91亿元 同比减少6.73%
华润医药(03320):华润双鹤前三季度净利润约13.07亿元,同比减少6.51%
智通财经 · 10-27
华润医药(03320):华润双鹤前三季度净利润约13.07亿元,同比减少6.51%
华润医药2026年前三季度营收80.66亿元,净利润13.07亿元
公告速递 · 10-27
华润医药2026年前三季度营收80.66亿元,净利润13.07亿元
华润医药(03320):华润三九前9个月净利润约26.01亿元 同比减少10.28%
智通财经 · 10-23
华润医药(03320):华润三九前9个月净利润约26.01亿元 同比减少10.28%
华润医药2026年前三季度营收214.10亿元,经调整净利润26.01亿元
公告速递 · 10-23
华润医药2026年前三季度营收214.10亿元,经调整净利润26.01亿元
华润医药(03320.HK):昆药集团前9个月净亏损约3.63亿元 同比盈转亏
智通财经 · 10-23
华润医药(03320.HK):昆药集团前9个月净亏损约3.63亿元 同比盈转亏
华润医药2026年第三财季营收27.22亿元,净利润-3.63亿元
公告速递 · 10-23
华润医药2026年第三财季营收27.22亿元,净利润-3.63亿元
华润医药(03320.HK):华润江中前三季度净利润6.88亿元 同比减少7.32%
智通财经 · 10-23
华润医药(03320.HK):华润江中前三季度净利润6.88亿元 同比减少7.32%
华润医药2026年前三季度营收26.62亿元,净利润6.88亿元
公告速递 · 10-23
华润医药2026年前三季度营收26.62亿元,净利润6.88亿元
华润医药2026年前三季度营收49.40亿元,经调整后净利润13.28亿元
公告速递 · 10-23
华润医药2026年前三季度营收49.40亿元,经调整后净利润13.28亿元
华润医药(03320.HK):东阿阿胶前9个月净利润约13.28亿元,同比增长4.02%
智通财经 · 10-23
华润医药(03320.HK):东阿阿胶前9个月净利润约13.28亿元,同比增长4.02%
华润医药2026年前三季度营收60.74亿元,经调整净利润10.87亿元
公告速递 · 10-23
华润医药2026年前三季度营收60.74亿元,经调整净利润10.87亿元
华润医药(03320)完成发行8亿元第三期2026年中期票据 票面利率1.45%
公告速递 · 10-23
华润医药(03320)完成发行8亿元第三期2026年中期票据 票面利率1.45%
华润医药(03320)附属完成发行8亿元中期票据
智通财经 · 10-23
华润医药(03320)附属完成发行8亿元中期票据
加载更多
公司概况
公司名称:
华润医药
所属市场:
SEHK
上市日期:
--
主营业务:
华润医药集团有限公司是一家主要从事医药业务的投资控股公司。该公司通过四个分部运营业务。制药业务分部研发、制造及销售一系列药品及保健品。药品分销业务分部向医院、分销商及零售药店等药品制造商、器械制造商及配药商提供分销、仓储、物流及其他药品供应链增值解决方案及相关服务。药品零售业务分部经营零售药店。其他业务营运分部从事持有物业及其他业务。
发行价格:
--
{"stockData":{"symbol":"03320","market":"HK","secType":"STK","nameCN":"华润医药","latestPrice":4.635,"timestamp":1794291687906,"preClose":4.665,"halted":0,"volume":2411000,"delay":0,"changeRate":-0.006430868167202625,"floatShares":6282510461,"shares":6283000000,"eps":0.643391,"marketStatus":"交易中","change":-0.03,"latestTime":"11-10 14:21:46","open":4.665,"high":4.675,"low":4.62,"amount":11182301,"amplitude":0.01179,"askPrice":4.635,"askSize":38500,"bidPrice":4.625,"bidSize":22500,"shortable":3,"etf":0,"ttmEps":0.763522,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1794298200000},"marketStatusCode":2,"adr":0,"listingDate":1477584000000,"exchange":"SEHK","adjPreClose":4.665,"dividendRate":0.051737,"openAndCloseTimeList":[[1794274200000,1794283200000],[1794286800000,1794297600000]],"volumeRatio":0.423291,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03320","defaultTab":"news","newsList":[{"id":"1185575621","title":"华润医药10月股份变动月报表,股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1185575621","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185575621?lang=zh_cn&edition=full","pubTime":"2026-11-02 17:33","pubTimestamp":1793612022,"startTime":"0","endTime":"0","summary":"华润医药集团有限公司(股票代码:03320)于2026年11月2日披露截至2026年10月31日的股份变动月报表。报告期内,公司已发行股份总数为6,282,510,461股,与上月末持平,未见新增发行、购回、注销或库存股变动。\n根据公告,公司期末股份期权总数为628,450,646份,该期权计划经股东大会于2017年12月12日批准。本月内无行使、转让或作废的记录,公司注册股本亦无变化。同时,公司确认已满足香港联交所对于最低公众持股量的规定。\n本次公告由公司秘书温詠宜签署。公司表示,将继续遵守香港联交所《上市规则》及相关法律法规的要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679299392","title":"华润医药(03320.HK):华润医药商业前三季度归母净利润14.2亿元 同比增长5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679299392","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679299392?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:27","pubTimestamp":1793352441,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","03320","BK1570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135881192","title":"华润医药2026年前三季度营收1694.60亿元,净利润17.46亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1135881192","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135881192?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:22","pubTimestamp":1793352167,"startTime":"0","endTime":"0","summary":"本季度信息\n据公告披露,华润医药在2026年前三季度实现营业收入约人民币1694.60亿元,相比去年同期的约1651.01亿元增长2.64%。同期净利润达人民币17.46亿元,同比增长3.64%。\n从成本端看,报告期内该公司营业成本为1586.56亿元,销售费用和管理费用分别为43.67亿元与18.97亿元,研发费用约0.17亿元;与去年同期相比,研发投入有所回落。财务费用在本期为10.10亿元。\n经营现金流方面,2026年前三季度经营活动产生的现金流量净额约3.28亿元,去年同期为净流出约3624.72万元,现金流表现有所改善。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121219049","title":"华润医药2026年前三季度营收8.47亿元,净利润6,058.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1121219049","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1121219049?lang=zh_cn&edition=full","pubTime":"2026-10-29 17:22","pubTimestamp":1793265724,"startTime":"0","endTime":"0","summary":"本季度信息\n2026年10月29日,华润医药旗下华润博雅生物公告了截至2026年9月30日止九个月的财务业绩。根据中国公认会计准则(未经审计)编制,其报告期内实现营业总收入8.47亿元,同比下降42.53%。净利润为6,058.83万元,同比下降82.36%。\n同期内,公司现金及现金等价物净减少8,134.43万元,期末现金及现金等价物余额为4.42亿元。截至2026年9月30日,总资产为82.51亿元,总负债为8.01亿元,所有者权益为74.50亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679476443","title":"华润医药(03320.HK):华润博雅生物前三季度净利润6058.83万元 同比减少82.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679476443","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679476443?lang=zh_cn&edition=full","pubTime":"2026-10-29 17:20","pubTimestamp":1793265652,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1570","03320","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112283304","title":"华润医药2026年前三季度营收2035.28亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112283304","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112283304?lang=zh_cn&edition=full","pubTime":"2026-10-28 17:56","pubTimestamp":1793181414,"startTime":"0","endTime":"0","summary":"截至2026年9月30日止九个月,华润医药实现营收2035.28亿元,同比上年同期的2008.81亿元增长约1.32%。同期营业成本总额为1705.66亿元,毛利率约16.19%,较上年同期的16.70%略有下降。报告期内,营业利润为85.23亿元,对应的经营利润率约4.19%,上年同期为4.62%。经营活动现金净流入约为48.52亿元,反映出公司在销售回款方面保持一定稳健性。其他业务收入约13.37亿元,相较上年同期的14.80亿元略有下滑。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2678816450","title":"华润医药(03320):华润医药控股前三季度归母净利润23.91亿元 同比减少6.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678816450","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678816450?lang=zh_cn&edition=full","pubTime":"2026-10-28 17:54","pubTimestamp":1793181282,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布华润医药控股截至2026年9月30日止9个月业绩,该公司取得营业收入人民币2035.28亿元,同比增加1.32%;归属于母公司所有者的净利润23.91亿元,同比减少6.73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1514283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678273871","title":"华润医药(03320):华润双鹤前三季度净利润约13.07亿元,同比减少6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678273871","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678273871?lang=zh_cn&edition=full","pubTime":"2026-10-27 17:37","pubTimestamp":1793093823,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)公布华润双鹤2026年前三季度业绩,营业总收入约80.66亿元,同比减少4%;净利润约13.07亿元,同比减少6.51%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1513367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","600062"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134069952","title":"华润医药2026年前三季度营收80.66亿元,净利润13.07亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134069952","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134069952?lang=zh_cn&edition=full","pubTime":"2026-10-27 17:36","pubTimestamp":1793093797,"startTime":"0","endTime":"0","summary":"根据华润医药旗下控股子公司华润双鹤公布的截至2026年9月30日止九个月未经审计财务数据,营收约80.66亿元,同比去年同期的84.02亿元下降约4.00%。同期净利润录得约13.07亿元,相较上年同期的13.99亿元下降约6.51%。报告期内,华润双鹤的现金及现金等价物净增加额约为2.11亿元,上年同期为净减少6.30亿元,期末现金及现金等价物余额为21.19亿元。目前,华润医药透过其附属公司合计持有华润双鹤60.26%的权益。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677624929","title":"华润医药(03320):华润三九前9个月净利润约26.01亿元 同比减少10.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677624929","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677624929?lang=zh_cn&edition=full","pubTime":"2026-10-23 19:24","pubTimestamp":1792754648,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)公布华润三九2026年前9个月业绩,营业总收入约214.1亿元,同比减少2.62%;净利润约26.01亿元,同比减少10.28%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1511762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000999","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148541830","title":"华润医药2026年前三季度营收214.10亿元,经调整净利润26.01亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1148541830","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1148541830?lang=zh_cn&edition=full","pubTime":"2026-10-23 19:22","pubTimestamp":1792754538,"startTime":"0","endTime":"0","summary":"本季度信息\n华润医药于2026年10月23日公告,子公司华润三九截至2026年9月30日止九个月实现营收214.10亿元,同比下降2.62%。经调整净利润为26.01亿元,同比下降10.23%。期内,现金及现金等价物净减少额为17.16亿元,期末现金及现金等价物余额为28.00亿元。报告显示,公司的总资产达到554.37亿元,总负债为166.71亿元,所有者权益约387.66亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677925163","title":"华润医药(03320.HK):昆药集团前9个月净亏损约3.63亿元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2677925163","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677925163?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:39","pubTimestamp":1792751952,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1570","03320","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124049518","title":"华润医药2026年第三财季营收27.22亿元,净利润-3.63亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1124049518","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124049518?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:36","pubTimestamp":1792751772,"startTime":"0","endTime":"0","summary":"本季度信息\n华润医药于2026年10月23日发布的公告显示,其附属公司昆药集团截至2026年9月30日止九个月的营业总收入约为27.22亿元(人民币,下同),与2025年同期的47.51亿元相比,同比下降约42.7%。期内净利润由上年同期3.23亿元转为亏损3.63亿元,降幅约为212%。\n公告同时显示,截至报告期末,昆药集团总资产约为105.24亿元,总负债约为40.80亿元,所有者权益约为64.44亿元。与此同时,期末现金及现金等价物余额约为3.69亿元。\n业务分项\n(公告未披露具体业务板块营收与增幅情况,故此处暂不列示。)\n高管解读\n(公告未公开高管相关表述,故此处暂不列示。)","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677589925","title":"华润医药(03320.HK):华润江中前三季度净利润6.88亿元 同比减少7.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677589925","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677589925?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:33","pubTimestamp":1792751618,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1570","BK1191","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179860077","title":"华润医药2026年前三季度营收26.62亿元,净利润6.88亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179860077","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179860077?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:33","pubTimestamp":1792751583,"startTime":"0","endTime":"0","summary":"华润医药旗下非全资子公司华润江中于2026年10月23日公布了截至2026年9月30日止九个月的未经审计财务业绩。报告期内,华润江中实现营业总收入约26.62亿元,同比下降9.25%;同期净利润约6.88亿元,同比下降7.32%。同期华润江中现金及现金等价物净减少约4.26亿元,期末现金及现金等价物余额约2.83亿元。截至2026年9月30日,华润江中总资产达到约66.33亿元,负债总额约21.28亿元,所有者权益约45.05亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152944810","title":"华润医药2026年前三季度营收49.40亿元,经调整后净利润13.28亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1152944810","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152944810?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:27","pubTimestamp":1792751270,"startTime":"0","endTime":"0","summary":"根据公司公告,华润医药下属子公司东阿阿胶在截至2026年9月30日止九个月内,实现营收49.40亿元,较去年同期的47.66亿元增长3.65%。同期,经调整后净利润为13.28亿元,较上年同期的12.77亿元增长4.00%。公告显示,东阿阿胶财务数据依据中国公认会计准则编制,尚未经审阅或审计。期内,东阿阿胶的现金及现金等价物净额由上年同期的5.10亿元增加额转为7.63亿元净减少,期末现金及现金等价物余额为26.43亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677221923","title":"华润医药(03320.HK):东阿阿胶前9个月净利润约13.28亿元,同比增长4.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677221923","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677221923?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:26","pubTimestamp":1792751176,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1570","BK1191","03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154498431","title":"华润医药2026年前三季度营收60.74亿元,经调整净利润10.87亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1154498431","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154498431?lang=zh_cn&edition=full","pubTime":"2026-10-23 18:11","pubTimestamp":1792750308,"startTime":"0","endTime":"0","summary":"截至2026年9月30日止九个月,华润医药通过其非全资附属公司天士力医药实现营收60.74亿元(去年同期63.11亿元),同比下降3.76%;净利润10.87亿元(去年同期9.93亿元),同比增长9.52%。\n天士力医药报告期内现金及现金等价物净减少4.78亿元,期末现金及现金等价物余额为9.37亿元。同期末,总资产达150.65亿元,总负债为20.22亿元,所有者权益130.43亿元。上述财务数据基于中国公认会计准则编制,仅代表天士力医药经营业绩并不全面反映华润医药整体财务状况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194376380","title":"华润医药(03320)完成发行8亿元第三期2026年中期票据 票面利率1.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194376380","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194376380?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:57","pubTimestamp":1792749423,"startTime":"0","endTime":"0","summary":"2026年10月23日,华润医药集团有限公司(03320)公告披露,其全资附属公司华润医药控股有限公司已在中国境内完成发行第三期2026年中期票据。本次票据发行要点如下:\n1. 发行规模:人民币8亿元。\n2. 期限:三年,到期日为2029年。\n3. 票面年利率:1.45%。\n4. 募集资金用途:拟用于偿还有息债务及其他符合适用法律法规的用途。\n公司称,相关发行已全部完成。公司亦提醒股东及潜在投资者在买卖公司证券时保持审慎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677940186","title":"华润医药(03320)附属完成发行8亿元中期票据","url":"https://stock-news.laohu8.com/highlight/detail?id=2677940186","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677940186?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:48","pubTimestamp":1792748916,"startTime":"0","endTime":"0","summary":"智通财经APP讯,华润医药(03320)发布公告,本公司的全资附属公司华润医药控股有限公司(华润医药控股)已于中国完成发行第三期2026年中期票据(第三期2026年中期票据)。本金额人民币8亿元的第三期2026年中期票据已发行,期限三年,票面年利率为1.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1511614.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","BK1570","BK1191"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crpharm.com","stockEarnings":[{"period":"1week","weight":0.0174},{"period":"1month","weight":0.0651},{"period":"3month","weight":-0.0269},{"period":"6month","weight":-0.0279},{"period":"1year","weight":0.0058},{"period":"ytd","weight":0.1052}],"compareEarnings":[{"period":"1week","weight":0.0451},{"period":"1month","weight":0.0098},{"period":"3month","weight":-0.0469},{"period":"6month","weight":-0.0735},{"period":"1year","weight":-0.0683},{"period":"ytd","weight":-0.0461}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华润医药集团有限公司是一家主要从事医药业务的投资控股公司。该公司通过四个分部运营业务。制药业务分部研发、制造及销售一系列药品及保健品。药品分销业务分部向医院、分销商及零售药店等药品制造商、器械制造商及配药商提供分销、仓储、物流及其他药品供应链增值解决方案及相关服务。药品零售业务分部经营零售药店。其他业务营运分部从事持有物业及其他业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.012707},{"month":2,"riseRate":0.7,"avgChangeRate":0.04534},{"month":3,"riseRate":0.5,"avgChangeRate":0.003155},{"month":4,"riseRate":0.7,"avgChangeRate":0.030364},{"month":5,"riseRate":0.5,"avgChangeRate":0.000616},{"month":6,"riseRate":0.3,"avgChangeRate":-0.002096},{"month":7,"riseRate":0.3,"avgChangeRate":-0.023787},{"month":8,"riseRate":0.4,"avgChangeRate":-0.009791},{"month":9,"riseRate":0.4,"avgChangeRate":-0.016796},{"month":10,"riseRate":0.3,"avgChangeRate":-0.020239},{"month":11,"riseRate":0.454545,"avgChangeRate":0.00986},{"month":12,"riseRate":0.5,"avgChangeRate":-0.000983}],"exchange":"SEHK","name":"华润医药","nameEN":"CHINARES PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润医药,03320,华润医药股票,华润医药股票老虎,华润医药股票老虎国际,华润医药行情,华润医药股票行情,华润医药股价,华润医药股市,华润医药股票价格,华润医药股票交易,华润医药股票购买,华润医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}